Testing effectiveness (Phase 2)UnknownNCT00979160What this trial is testingEvaluation of Response of Dasatinib to Treat MastocytosisWho this might be right forSystemic Mastocytosis Federico II University 30
Testing effectiveness (Phase 2)Study completedNCT00171912What this trial is testingImatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesWho this might be right forHypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more Novartis Pharmaceuticals 38
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Not applicableUnknownNCT06013683What this trial is testingA Registry for Patients With Systemic Mastocytosis in ChinaWho this might be right forSystemic Mastocytoses The First Affiliated Hospital of Soochow University 150
Not applicableStudy completedNCT00898079What this trial is testingCollecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With CancerWho this might be right forAcute Undifferentiated LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChildhood Acute Lymphoblastic Leukemia+11 more Children's Oncology Group 2,545
Large-scale testing (Phase 3)UnknownNCT04333108What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic TreatmentWho this might be right forIndolent Systemic Mastocytosis AB Science 140
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT02836067What this trial is testingImpact of Smoking and Its Cessation on Systemic and Airway Immune ActivationWho this might be right forHIVSmoking Boston Medical Center 53
Large-scale testing (Phase 3)Study completedNCT03401060What this trial is testingInterest of Denosumab Treatment in Osteoporosis Associated to Systemic MastocytosisWho this might be right forOsteoporosisSystemic Mastocytosis Assistance Publique - Hôpitaux de Paris 24
Testing effectiveness (Phase 2)Study completedNCT00782067What this trial is testingEfficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell LeukemiaWho this might be right forLeukemia Novartis Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT00449748What this trial is testingEverolimus (RAD001) as Therapy for Patients With Systemic MastocytosisWho this might be right forSystemic Mastocytosis M.D. Anderson Cancer Center 10
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00627666What this trial is testingDonor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Asan Medical Center 52
Not applicableLooking for participantsNCT06985420What this trial is testingThe Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance ExerciseWho this might be right forHealthy WomenMenstruationResistance Exercise University of Central Florida 40
Not applicableStudy completedNCT00785018What this trial is testingIn Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human EndotoxemiaWho this might be right forEndotoxemiaInflammationMulti Organ Dysfunction Syndrome Radboud University Medical Center 20
Not applicableLooking for participantsNCT06131775What this trial is testingCharacterisation of TLR4+ Blood Cells in Patients With Solid CancerWho this might be right forAll Types of Solid Cancer Hospices Civils de Lyon 300
Early research (Phase 1)Study completedNCT02561988What this trial is testing(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid MalignanciesWho this might be right forAggressive Systemic MastocytosisSystemic Mastocytosis-associated Hematologic Non-mast Cell DiseaseMast Cell Leukemia+1 more Blueprint Medicines Corporation 86
Testing effectiveness (Phase 2)Study completedNCT00233454What this trial is testingPhase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell LeukemiaWho this might be right forSystemic Mastocytosis, Aggressive (ASM)Leukemia, Mast CellHematological Non-mast Cell Lineage Disease (AHNMD) Jason Robert Gotlib 26
Testing effectiveness (Phase 2)Study completedNCT02121756What this trial is testingDipyridamole for Immune Activation in HIVWho this might be right forHIV Infection Sharon Riddler 40
Early research (Phase 1)Study completedNCT02808793What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002Who this might be right forIndolent Systemic Mastocytosis Allakos Inc. 25